CRWV is trading at +4.4% now at $83.67 after Goldman Sachs initiated coverage with a Neutral rating and $86 price target.
- The move follows positive momentum in partner Core Scientific after a BTIG upgrade post-merger rejection.
- Gains are supported by underlying AI infrastructure strength and a massive $55.6B backlog.
- The price action occurs amid a slightly down market, suggesting strong stock-specific momentum.